Michael J Pishvaian Selected Research

Michael J Pishvaian Research Topics

Disease

52	Neoplasms (Cancer) 01/2023 - 07/2002
26	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 11/2012
16	Adenocarcinoma 01/2023 - 12/2008
5	Disease Progression 01/2021 - 11/2012
4	Breast Neoplasms (Breast Cancer) 01/2018 - 07/2002
3	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 01/2011
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2016
2	Exanthema (Rash) 11/2020 - 12/2018
2	Diarrhea 11/2020 - 12/2018
2	Fatigue 12/2018 - 01/2018
2	Carcinogenesis 05/2015 - 05/2011
1	Cicatrix (Scar) 01/2023
1	Pancreatitis 01/2021
1	Colitis 11/2020
1	Fever (Fevers) 11/2020
1	Hematologic Neoplasms (Hematological Malignancy) 11/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020
1	Primitive Neuroectodermal Tumors (PNET) 01/2020
1	Carcinoid Tumor (Carcinoid) 01/2020
1	Genomic Instability 11/2019
1	Microsatellite Instability 08/2019
1	Aggressive Fibromatosis (Desmoid) 12/2018
1	Hypertension (High Blood Pressure) 12/2018
1	Margins of Excision 01/2018

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2007
9	Gemcitabine FDA Link 01/2021 - 03/2013
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2011
6	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021 - 01/2014
5	Capecitabine (Xeloda)FDA Link 01/2021 - 05/2014
5	Lapatinib (GW572016)FDA Link 11/2019 - 05/2015
5	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 05/2015
4	veliparibIBA 12/2021 - 11/2015
4	Fluorouracil (Carac)FDA LinkGeneric 10/2020 - 05/2014
4	LigandsIBA 01/2020 - 06/2012
3	folfirinoxIBA 01/2023 - 03/2017
3	PlatinumIBA 01/2023 - 04/2017
3	Phosphotransferases (Kinase)IBA 11/2019 - 12/2015
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2017 - 06/2012
3	Cetuximab (Erbitux)FDA Link 05/2015 - 01/2011
3	ixabepilone (BMS 247550)FDA Link 05/2014 - 12/2012
2	130-nm albumin-bound paclitaxelIBA 01/2023 - 03/2017
2	AntibodiesIBA 11/2022 - 12/2019
2	B7-H1 AntigenIBA 01/2022 - 08/2017
2	Immune Checkpoint InhibitorsIBA 01/2022 - 08/2019
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2020 - 03/2017
2	ribociclibIBA 01/2020 - 01/2017
2	pembrolizumabIBA 01/2020 - 08/2017
2	utomilumabIBA 12/2019 - 01/2018
2	Monoclonal AntibodiesIBA 12/2019 - 08/2017
2	RNA (Ribonucleic Acid)IBA 08/2019 - 03/2017
2	Sorafenib (BAY 43-9006)FDA Link 12/2018 - 11/2015
2	Temozolomide (Temodar)FDA LinkGeneric 01/2018 - 11/2015
2	Irinotecan (Camptosar)FDA LinkGeneric 03/2017 - 01/2014
2	palbociclibIBA 01/2017 - 06/2012
2	Growth Factor ReceptorsIBA 12/2015 - 05/2015
2	taxaneIBA 01/2014 - 03/2013
1	Indicators and Reagents (Reagents)IBA 11/2022
1	NivolumabIBA 01/2022
1	varlilumabIBA 01/2022
1	Topoisomerase InhibitorsIBA 12/2021
1	AnthelminticsIBA 11/2021
1	pyrvinium (Vankin)FDA Link 11/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2021
1	osteoblast cadherinIBA 01/2021
1	temsirolimus FDA Link 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	CytokinesIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2020
1	idelalisibIBA 11/2020
1	Everolimus FDA Link 01/2020
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2020
1	mogamulizumabIBA 12/2019
1	CC ChemokinesIBA 12/2019
1	Bortezomib (Velcade)FDA Link 11/2019
1	Proteasome InhibitorsIBA 11/2019
1	abemaciclibIBA 10/2019
1	Cyclin-Dependent Kinase Inhibitor p16IBA 10/2019
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 10/2019
1	Thymidylate SynthaseIBA 01/2019
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	poly ADP-ribose glycohydrolaseIBA 01/2019
1	TabletsIBA 12/2018
1	entrectinibIBA 11/2018
1	O(6)-Methylguanine-DNA MethyltransferaseIBA 01/2018
1	Antimalarials (Antimalarial Agents)IBA 01/2018
1	Transaminases (Aminotransferases)IBA 01/2018
1	EnzymesIBA 01/2018
1	ArtesunateIBA 01/2018

Therapy/Procedure

28	Therapeutics 01/2023 - 08/2010
12	Drug Therapy (Chemotherapy) 01/2023 - 12/2008
5	Precision Medicine 06/2020 - 06/2017
3	Radiotherapy 04/2017 - 11/2012
2	Immunotherapy 01/2022 - 08/2019
2	Adjuvant Chemotherapy 01/2018 - 05/2014
2	Chemoprevention 06/2012 - 03/2011
1	Oral Administration 11/2021
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021
1	Injections 01/2021